Matregenix Awarded $2M NIH Phase II SBIR Grant to Advance MatriNova Platform for Bone Regeneration
Phase II award from NIH’s National Institute of Dental & Craniofacial Research will drive development of MatriNova, an amino acid-based nanofiber membrane for guided bone regeneration (GBR), in collaboration with University of Michigan; marks Matregenix’s… Read More »Matregenix Awarded $2M NIH Phase II SBIR Grant to Advance MatriNova Platform for Bone Regeneration




